We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Firms “Under-invest” in Long-Term Cancer Research

News   Jul 30, 2015

 
Firms “Under-invest” in Long-Term Cancer Research
 
 
 

RELATED ARTICLES

Shortcut to Recreating Key HIV Antibody for Vaccines

News

A portion of the roadmap toward effective neutralization of HIV has been clarified, identifying the steps that a critical HIV antibody takes to develop and maintain its ability to neutralize the virus.

READ MORE

Drug Cocktail Cripples Cancer Cells

News

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

READ MORE

50% of Trial Subjects Who Took a Placebo Reported Suffering an Adverse Event

News

Research published today in Trials explores the negative effects that can be caused by participants being administered placebos in clinical trials, finding that half of people taking placebos reported side effects from the trial intervention.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE